FIELD: biotechnology.
SUBSTANCE: disclosed are antibodies for binding with phentanyl, a phentanyl analogue or carfentanil, pharmaceutical compositions containing said antibodies, and the use of antibodies and pharmaceutical compositions for the treatment or prevention of opioid overdoses, for the treatment of opioid use disorder, and for the treatment or prevention of opioid-induced respiratory failure.
EFFECT: invention can find further application in opioid dependence therapy.
18 cl, 22 dwg, 7 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
TRISPECIFIC BINDING PROTEINS, RELATED METHODS AND VERSIONS OF USE THEREOF | 2020 |
|
RU2822200C2 |
BISPECIFIC ANTIBODIES TO CCL2 | 2020 |
|
RU2819613C1 |
ISOFORM-SELECTIVE ANTI-TGF-BETA ANTIBODIES AND METHODS FOR USE THEREOF | 2021 |
|
RU2839151C1 |
C3 BINDING AGENTS AND METHODS OF THEIR USE | 2019 |
|
RU2802307C2 |
PROCOAGULANT ANTIBODIES | 2018 |
|
RU2810094C2 |
ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018 |
|
RU2795485C2 |
METHODS FOR DETECTING FOLATE RECEPTOR 1 IN PATIENT SAMPLE | 2018 |
|
RU2759410C2 |
ANTIBODIES THAT BIND TO CANCER CELLS AND PROVIDE TARGETED TRANSFER OF RADIONUCLIDES TO SAID CELLS | 2020 |
|
RU2833191C2 |
TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS USING CROSSOVER FORMAT WITH DOUBLE VARIABLE DOMAIN (CODV) FOR TREATING INFECTION CAUSED BY HIV | 2020 |
|
RU2820164C2 |
ANTIBODY AGAINST MUC1 | 2019 |
|
RU2792347C2 |
Authors
Dates
2025-06-05—Published
2021-11-08—Filed